Impact of Intravascular Imaging-Guided Stent Optimization According to Clinical Presentation in Patients Undergoing Complex PCI
Sang Yoon Lee,Ki Hong Choi,Chan Joon Kim,Joo Myung Lee,Young Bin Song,Jong-Young Lee,Seung-Jae Lee,Sang Yeub Lee,Sang Min Kim,Kyeong Ho Yun,Jae Young Cho,Hyo-Suk Ahn,Chang-Wook Nam,Hyuck-Jun Yoon,Yong Hwan Park,Wang Soo Lee,Jin-Ok Jeong,Pil Sang Song,Sung Eun Kim,Joon-Hyung Doh,Sang-Ho Jo,Chang-Hwan Yoon,Min Gyu Kang,Jin-Sin Koh,Kwan Yong Lee,Young-Hyo Lim,Yun-Hyeong Cho,Jin-Man Cho,Woo Jin Jang,Kook-Jin Chun,David Hong,Taek Kyu Park,Jeong Hoon Yang,Seung-Hyuk Choi,Hyeon-Cheol Gwon,Joo-Yong Hahn
DOI: https://doi.org/10.1016/j.jcin.2024.03.021
IF: 11.075
2024-05-29
JACC Cardiovascular Interventions
Abstract:Background It is unclear whether the beneficial effects of intravascular imaging–guided stent optimization vary by clinical presentation during complex percutaneous coronary intervention (PCI). Objectives In this prespecified, stratified subgroup analysis from RENOVATE-COMPLEX-PCI (Randomized Controlled Trial of Intravascular Imaging Guidance versus Angiography-Guidance on Clinical Outcomes After Complex PCI), we sought to compare the outcomes between intravascular imaging vs angiography guidance according to clinical presentation. Methods Patients with complex coronary artery lesions were randomly assigned to undergo either intravascular imaging–guided PCI or angiography-guided PCI in a 2:1 ratio. The primary endpoint was target vessel failure (TVF), which is a composite of cardiac death, target vessel–related myocardial infarction, or clinically driven target vessel revascularization. Results Of 1,639 patients, 832 (50.8%) presented with acute coronary syndrome (ACS) and 807 (49.2%) with chronic coronary syndrome. During a median follow-up of 2.1 years (Q1-Q3: 1.4-3.0 years), there was no significant interaction between the treatment effect of intravascular imaging and clinical presentation ( P for interaction = 0.19). Among patients with ACS, the incidences of TVF were 10.4% in the intravascular imaging group and 14.6% in the angiography group (HR: 0.74; 95% CI: 0.48-1.15; P = 0.18). Among patients with CCS, the incidences of TVF were 5.0% in the intravascular imaging group and 10.4% in the angiography group (HR: 0.46; 95% CI: 0.27-0.80; P = 0.006). Achieving stent optimization by intravascular imaging resulted in a reduced risk of TVF among patients with ACS who were randomly assigned to intravascular imaging–guided PCI for complex coronary lesions (optimized vs unoptimized, 6.5% vs 14.1%; HR: 0.49; 95% CI: 0.27-0.87; P = 0.02) but not those with CCS (5.4% vs 4.7%, HR: 1.18; 95% CI: 0.53-2.59; P = 0.69). Conclusions No significant interaction was observed between the benefits of intravascular imaging and clinical presentation in the risk of TVF. Stent optimization by intravascular imaging was particularly important for ACS patients. (Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention For Complex Coronary Artery Disease [RENOVATE]; NCT03381872 )
cardiac & cardiovascular systems